116 related articles for article (PubMed ID: 8547115)
1. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia.
Bosch F; Campo E; Jares P; Pittaluga S; Muñoz J; Nayach I; Piris MA; Dewolf-Peeters C; Jaffe ES; Rozman C
Br J Haematol; 1995 Dec; 91(4):1025-30. PubMed ID: 8547115
[TBL] [Abstract][Full Text] [Related]
2. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Bosch F; Jares P; Campo E; Lopez-Guillermo A; Piris MA; Villamor N; Tassies D; Jaffe ES; Montserrat E; Rozman C
Blood; 1994 Oct; 84(8):2726-32. PubMed ID: 7919385
[TBL] [Abstract][Full Text] [Related]
3. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the CCND1 gene in hairy cell leukemia.
de Boer CJ; Kluin-Nelemans JC; Dreef E; Kester MG; Kluin PM; Schuuring E; van Krieken JH
Ann Oncol; 1996 Mar; 7(3):251-6. PubMed ID: 8740788
[TBL] [Abstract][Full Text] [Related]
5. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
6. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
8. Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.
Rimokh R; Berger F; Bastard C; Klein B; French M; Archimbaud E; Rouault JP; Santa Lucia B; Duret L; Vuillaume M
Blood; 1994 Jun; 83(12):3689-96. PubMed ID: 8204893
[TBL] [Abstract][Full Text] [Related]
9. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
Jadayel D; Matutes E; Dyer MJ; Brito-Babapulle V; Khohkar MT; Oscier D; Catovsky D
Blood; 1994 Jun; 83(12):3664-71. PubMed ID: 8204891
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma.
Davidson BJ; Lydiatt WM; Abate MP; Schantz SP; Chaganti RS
Head Neck; 1996; 18(6):512-21. PubMed ID: 8902564
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Williams ME; Swerdlow SH
Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823
[TBL] [Abstract][Full Text] [Related]
12. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
de Boer CJ; Loyson S; Kluin PM; Kluin-Nelemans HC; Schuuring E; van Krieken JH
Cancer Res; 1993 Sep; 53(18):4148-52. PubMed ID: 8364907
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
Leukemia; 1993 Feb; 7(2):241-5. PubMed ID: 8426477
[TBL] [Abstract][Full Text] [Related]
14. Implication of cyclin D1 in malignant lymphoma.
Callanan M; Leroux D; Magaud JP; Rimokh R
Crit Rev Oncog; 1996; 7(3-4):191-203. PubMed ID: 9258602
[TBL] [Abstract][Full Text] [Related]
15. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders.
Sola B; Salaün V; Ballet JJ; Troussard X
Int J Cancer; 1999 Oct; 83(2):230-4. PubMed ID: 10471532
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
Maelandsmo GM; Berner JM; Flørenes VA; Forus A; Hovig E; Fodstad O; Myklebost O
Br J Cancer; 1995 Aug; 72(2):393-8. PubMed ID: 7640224
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
[TBL] [Abstract][Full Text] [Related]
19. Centrocytic lymphoma: a B-cell non-Hodgkin's lymphoma characterized by chromosome 11 bcl-1 and PRAD 1 rearrangements.
Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
Curr Top Microbiol Immunol; 1992; 182():325-9. PubMed ID: 1490371
[No Abstract] [Full Text] [Related]
20. Bcl-1/cyclin D1 in malignant lymphoma.
de Boer CJ; van Krieken JH; Schuuring E; Kluin PM
Ann Oncol; 1997; 8 Suppl 2():109-17. PubMed ID: 9209653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
